These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cognitive reserve and TMEM106B genotype modulate brain damage in presymptomatic frontotemporal dementia: a GENFI study. Premi E; Grassi M; van Swieten J; Galimberti D; Graff C; Masellis M; Tartaglia C; Tagliavini F; Rowe JB; Laforce R; Finger E; Frisoni GB; de Mendonça A; Sorbi S; Gazzina S; Cosseddu M; Archetti S; Gasparotti R; Manes M; Alberici A; Cardoso MJ; Bocchetta M; Cash DM; Ourselin S; Padovani A; Rohrer JD; Borroni B; Brain; 2017 Jun; 140(6):1784-1791. PubMed ID: 28460069 [TBL] [Abstract][Full Text] [Related]
3. Rates of Brain Atrophy Across Disease Stages in Familial Frontotemporal Dementia Associated With MAPT, GRN, and C9orf72 Pathogenic Variants. Staffaroni AM; Goh SM; Cobigo Y; Ong E; Lee SE; Casaletto KB; Wolf A; Forsberg LK; Ghoshal N; Graff-Radford NR; Grossman M; Heuer HW; Hsiung GR; Kantarci K; Knopman DS; Kremers WK; Mackenzie IR; Miller BL; Pedraza O; Rascovsky K; Tartaglia MC; Wszolek ZK; Kramer JH; Kornak J; Boeve BF; Boxer AL; Rosen HJ; JAMA Netw Open; 2020 Oct; 3(10):e2022847. PubMed ID: 33112398 [TBL] [Abstract][Full Text] [Related]
4. Comparison of clinical rating scales in genetic frontotemporal dementia within the GENFI cohort. Peakman G; Russell LL; Convery RS; Nicholas JM; Van Swieten JC; Jiskoot LC; Moreno F; Sanchez-Valle R; Laforce R; Graff C; Masellis M; Tartaglia MC; Rowe JB; Borroni B; Finger E; Synofzik M; Galimberti D; Vandenberghe R; de Mendonça A; Butler CR; Gerhard A; Ducharme S; Le Ber I; Tagliavini F; Santana I; Pasquier F; Levin J; Danek A; Otto M; Sorbi S; Rohrer JD; J Neurol Neurosurg Psychiatry; 2022 Feb; 93(2):158-168. PubMed ID: 34353857 [TBL] [Abstract][Full Text] [Related]
5. TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia. van Blitterswijk M; Mullen B; Nicholson AM; Bieniek KF; Heckman MG; Baker MC; DeJesus-Hernandez M; Finch NA; Brown PH; Murray ME; Hsiung GY; Stewart H; Karydas AM; Finger E; Kertesz A; Bigio EH; Weintraub S; Mesulam M; Hatanpaa KJ; White CL; Strong MJ; Beach TG; Wszolek ZK; Lippa C; Caselli R; Petrucelli L; Josephs KA; Parisi JE; Knopman DS; Petersen RC; Mackenzie IR; Seeley WW; Grinberg LT; Miller BL; Boylan KB; Graff-Radford NR; Boeve BF; Dickson DW; Rademakers R Acta Neuropathol; 2014 Mar; 127(3):397-406. PubMed ID: 24385136 [TBL] [Abstract][Full Text] [Related]
6. Defining the association of TMEM106B variants among frontotemporal lobar degeneration patients with GRN mutations and C9orf72 repeat expansions. Lattante S; Le Ber I; Galimberti D; Serpente M; Rivaud-Péchoux S; Camuzat A; Clot F; Fenoglio C; ; Scarpini E; Brice A; Kabashi E Neurobiol Aging; 2014 Nov; 35(11):2658.e1-2658.e5. PubMed ID: 25085782 [TBL] [Abstract][Full Text] [Related]
7. TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions. Gallagher MD; Suh E; Grossman M; Elman L; McCluskey L; Van Swieten JC; Al-Sarraj S; Neumann M; Gelpi E; Ghetti B; Rohrer JD; Halliday G; Van Broeckhoven C; Seilhean D; Shaw PJ; Frosch MP; Alafuzoff I; Antonell A; Bogdanovic N; Brooks W; Cairns NJ; Cooper-Knock J; Cotman C; Cras P; Cruts M; De Deyn PP; DeCarli C; Dobson-Stone C; Engelborghs S; Fox N; Galasko D; Gearing M; Gijselinck I; Grafman J; Hartikainen P; Hatanpaa KJ; Highley JR; Hodges J; Hulette C; Ince PG; Jin LW; Kirby J; Kofler J; Kril J; Kwok JB; Levey A; Lieberman A; Llado A; Martin JJ; Masliah E; McDermott CJ; McKee A; McLean C; Mead S; Miller CA; Miller J; Munoz DG; Murrell J; Paulson H; Piguet O; Rossor M; Sanchez-Valle R; Sano M; Schneider J; Silbert LC; Spina S; van der Zee J; Van Langenhove T; Warren J; Wharton SB; White CL; Woltjer RL; Trojanowski JQ; Lee VM; Van Deerlin V; Chen-Plotkin AS Acta Neuropathol; 2014 Mar; 127(3):407-18. PubMed ID: 24442578 [TBL] [Abstract][Full Text] [Related]
8. White matter hyperintensities in progranulin-associated frontotemporal dementia: A longitudinal GENFI study. Sudre CH; Bocchetta M; Heller C; Convery R; Neason M; Moore KM; Cash DM; Thomas DL; Woollacott IOC; Foiani M; Heslegrave A; Shafei R; Greaves C; van Swieten J; Moreno F; Sanchez-Valle R; Borroni B; Laforce R; Masellis M; Tartaglia MC; Graff C; Galimberti D; Rowe JB; Finger E; Synofzik M; Vandenberghe R; de Mendonça A; Tagliavini F; Santana I; Ducharme S; Butler C; Gerhard A; Levin J; Danek A; Frisoni GB; Sorbi S; Otto M; Zetterberg H; Ourselin S; Cardoso MJ; Rohrer JD; Neuroimage Clin; 2019; 24():102077. PubMed ID: 31835286 [TBL] [Abstract][Full Text] [Related]
9. TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers. Finch N; Carrasquillo MM; Baker M; Rutherford NJ; Coppola G; Dejesus-Hernandez M; Crook R; Hunter T; Ghidoni R; Benussi L; Crook J; Finger E; Hantanpaa KJ; Karydas AM; Sengdy P; Gonzalez J; Seeley WW; Johnson N; Beach TG; Mesulam M; Forloni G; Kertesz A; Knopman DS; Uitti R; White CL; Caselli R; Lippa C; Bigio EH; Wszolek ZK; Binetti G; Mackenzie IR; Miller BL; Boeve BF; Younkin SG; Dickson DW; Petersen RC; Graff-Radford NR; Geschwind DH; Rademakers R Neurology; 2011 Feb; 76(5):467-74. PubMed ID: 21178100 [TBL] [Abstract][Full Text] [Related]
10. Association of TMEM106B gene polymorphism with age at onset in granulin mutation carriers and plasma granulin protein levels. Cruchaga C; Graff C; Chiang HH; Wang J; Hinrichs AL; Spiegel N; Bertelsen S; Mayo K; Norton JB; Morris JC; Goate A Arch Neurol; 2011 May; 68(5):581-6. PubMed ID: 21220649 [TBL] [Abstract][Full Text] [Related]
11. Alterations in Lysosomal, Glial and Neurodegenerative Biomarkers in Patients with Sporadic and Genetic Forms of Frontotemporal Dementia. Hsiao-Nakamoto J; Chiu CL; VandeVrede L; Ravi R; Vandenberg B; De Groot J; Tsogtbaatar B; Fang M; Auger P; Gould NS; Marchioni F; Powers CA; Davis SS; Suh JH; Alkabsh J; Heuer HW; Lago AL; Scearce-Levie K; Seeley WW; Boeve BF; Rosen HJ; Berger A; Tsai R; Di Paolo G; Boxer AL; Bhalla A; Huang F; bioRxiv; 2024 Feb; ():. PubMed ID: 38405775 [TBL] [Abstract][Full Text] [Related]
20. Expression of TMEM106B, the frontotemporal lobar degeneration-associated protein, in normal and diseased human brain. Busch JI; Martinez-Lage M; Ashbridge E; Grossman M; Van Deerlin VM; Hu F; Lee VM; Trojanowski JQ; Chen-Plotkin AS Acta Neuropathol Commun; 2013 Jul; 1():36. PubMed ID: 24252750 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]